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Periosteal chondrosarcoma (PC) is a rare low-grade malignant cartilaginous tumor originating on the bone surface.
Wide surgical resection is the recommended treatment. Prognosis is usually good if surgery is adequate. Metastasis
is late and very rare. We present the clinical, radiographic, and pathological features of a PC accompanied with
fibular cortical invasion in a 30-year-old woman. Wide resection was performed at presentation, but a whole-body
positron emission tomography/computed tomography (PET/CT) examination 10 months after operation showed
multiple bone metastases (MBM) especially in the spine, pelvis, bilateral femurs, and humeri without local recurrence.
To the best of our knowledge, the present report is the first concerning a PC with so extensive postoperative MBM but
without local recurrence.
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PC is a rare low-grade malignant cartilaginous tumor ori-
ginating on the bone surface, accounting for less than 2% of
all chondrosarcomas and about 0.2% of all bone tumors
[1-3]. Wide surgical resection is the recommended
treatment. Prognosis is usually good if surgery is ad-
equate. Metastasis is late and very rare [4].
We report a grade 2 PC with cortical invasion in the left
proximal fibula of a 30-year-old woman. MBM happened
especially in the spine, pelvis, bilateral femurs, and humeri
in the absence of local recurrence at 10 months after
operation.Case presentation
A 30-year-old woman presented with a 1-year history of a
gradually enlarging surface lesion on the posterolateral as-
pect of left proximal shank. She denied the history of in-
fection, major traumatic injury, and familial history of
cancer. Physical examination revealed a hard, painless,
motionless swelling on the posterolateral aspect of the left
proximal fibula. The overlying skin and local temperature
was normal. The left lower extremity demonstrated full* Correspondence: chongqitu@163.com
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tory data were within normal limits.
Plain radiograph showed a mass with ‘popcorn’ and
‘smoke ring’ pattern of calcification on the posterolateral
aspect of the left proximal fibula. The erosion of under-
lying cortex was not obvious (Figure 1A, B). A magnetic
resonance imaging (MRI) of the knees was done to as-
sess the extent and anatomical position of the mass.
MRI showed a vaguely lobulated solid mass measuring
5.5 × 5.0 × 4.5 cm on the posterolateral aspect of the left
proximal fibula. The mass exhibited homogeneous low
signal intense on T1-weight image (Figure 2A) and high
signal intense on T2-weight images (Figure 2B,C). Axial
T1-weight MRI with fat suppression showed cortical in-
vasion without marrow involvement (Figure 2D). A
whole-body bone scan with technetium-99 m-methyle-
nediphosphonate (Tc-MDP) showed strong accumula-
tion of the radiopharmaceutical agent on the outside
aspect of the left proximal fibula, without strong accu-
mulation in other parts of the body (Figure 3A).
Considering the above factors, a primary diagnosis of
periosteal malignancy was made, including PC, perios-
teal osteosarcoma, and parosteal osteosarcoma. Among
them, the most likely diagnosis was PC.
A wide resection was performed. The intraoperative
result of frozen section examination indicated a PC. Ac-
cording to the pathologic result, an en-bloc resection ofs is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Radiographs of the patient’s left shank. A, B
Anteroposterior and lateral views show a bone tumor with a ‘popcorn’
and ‘smoke ring’ pattern of calcification on the posterolateral aspect of
the left proximal fibula, respectively. C, D Postoperative radiographs
show the absence of the left proximal fibula and an anchor inserted
the lateral tibial metaphysis.
Liu et al. World Journal of Surgical Oncology  (2015) 13:121 Page 2 of 6the tumor and the left proximal fibula was performed.
The thickness of the excised normal soft tissues sur-
rounding the tumor and the length of excised fibula was
defined 1.0 and 8.5 cm, respectively. At surgery, the
common peroneal nerve was protected carefully and the
lateral collateral ligament was reattached to the lateral
tibial metaphysis with an anchor.
Postoperative pathological examination confirmed the
diagnosis of PC. Hematoxylin and eosin (H&E) staining
indicated a vaguely lobulated neoplastic hyaline cartilage
separated by fibrous bands and focal myxoid change(Figure 4A). The tumor cells enlarged and presented
moderate grade of atypia, including multiple and en-
larged nuclei. Mitoses were rare (Figure 4B). At high
magnification, the tumor cells were seen in the Volkman
canal (Figure 4C). The resection margins were clear. Ac-
cording to the above features and the grading system
used for conventional intramedullary chondrosarcomas
[1], the histopathological diagnosis of a PC (grade 2)
with cortical invasion was rendered.
The patient has been followed up for 16 months. Post-
operative recovery was uneventful in the initial follow-up
(Figure 1C, D). The patient, who was in a bad physical and
mental state, visited our bone tumor clinic with a pain in
pelvic region at 10 months after operation. On physical
examination, no clinical results were found except the
deep tenderness of sacral region and spine. A whole-body
bone scan demonstrated high uptake especially in the bi-
lateral iliac regions (Figure 3B).
In order to further define and assess the extent and
anatomical position of metastasis, PET/CT with 2-fluoro
[fluorine-18]-2-deoxy-D-glucose (F-18 FDG) was recom-
mended to be done. PET/CT showed focal F-18 FDG
uptake especially in the spine, pelvis, bilateral femurs,
and humeri, with a maximum SUV of 10.8, but with no
signs of local recurrence and no focal F-18 FDG uptake
in the brain, head, neck, chest, and abdomen except a
small nodule in the liver which was suspected as a cal-
cification (Figure 5). The histopathological result of the
needle biopsy of the ilium confirmed the diagnosis of
MBM of chondrosarcoma, and the grade of metastatic
chondrosarcoma was similar to that of primary PC
(Figure 4D, E).
Over the ensuing days, the patient received only the
palliative therapy such as analgesic treatment without
chemotherapy or radiotherapy. The patient died at
6 months after the definite diagnosis of MBM.Discussion
The mean age of PC is about 32 years (range, 20 to
40 years) [2,3,5]. The location mainly exists in the limbs,
including the distal femur, proximal tibia, and proximal
humerus [2-5]. PC of the fibula is still rare. There have
been only two case reports about PC of the fibula. Papa-
gelopoulos et al. [6] reported a PC (grade 2) of the left
distal fibula of a 31-year-old man measuring 2 cm in
size. Robinson et al. [7] also reported a PC of the right
distal fibula and tibia which induced the underling cor-
tex erosion without marrow invasion of a 64-year-old
woman. Lesions of PC are usually 4 to 20 cm in length
[2,5]; in most cases, they exceed 5 cm in maximum
diameter [5]. Robinson et al. [7] concluded that perios-
teal chondroid lesions greater than 3 cm in length
should be considered malignant.
Figure 2 MRI of tumor. A Sagittal T1-weight image shows a homogeneous hypo-intensity mass on the posterolateral aspect of the left proximal
fibula. B, C Sagittal and axial T2-weight images show a hyper-intensity mass (5.5 × 5.0 × 4.5 cm) with a multilobular configuration. D Axial T1-weighted
MRI with fat suppression shows the contrast enhancement around the tumor and cortical invasion (arrow).
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treatments for PC. Wide surgical resection with a suffi-
cient margin remains the recommended therapy for this
type of bone tumor. Prognosis is usually good if surgery
is adequate [4,8,9]. The reported incidence of local re-
currence varies from 13% to 28% and depends on theFigure 3 The whole-body bone scan of the patient. Bone scan shows s
aspect of the left proximal fibula preoperatively (A) and in bilateral iliac reg
the body.type of surgical treatment [6,10]. Even when local recur-
rence occur, the prognosis is still good if the wide resec-
tion can be performed again. Lung metastases, even
regional lymph node metastases, have been reported in
published literatures [6,11,12]. It is important to note
that the majority of lung metastases have inadequatetrong accumulation of the radiopharmaceutical agent on the outside
ions postoperatively (B) without strong accumulation in other parts of
Figure 4 Histological appearance of tumor (H&E). A Microscopic appearance of the tissue specimen dissected from the fibula lesion shows a
vaguely lobulated neoplastic hyaline cartilage separated by fibrous bands and focal myxoid change (×40). B High-power photomicrograph shows
the enlarged tumor cells with moderate grade of atypia and exhibits multiple, enlarged grotesque nuclei. Mitoses can be seen (×200). C The tumor cells
were seen in the Volkman canal (×200). D, E High-power photomicrograph of the tissue specimen from the needle biopsy of ilium shows a cartilaginous
lesion with hypercellularity and cytologic atypia (×100, ×200, respectively).
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company with local recurrence. Bone metastasis is even
rare. There have been few studies about bone metastasis
of chondrosarcoma. Ozaki et al. [13,14] reported two
cases of chondrosarcoma with bone metastasis and
found only five cases of chondrosarcoma with bony
metastases by reviewing literatures. They also found all
metastases mainly in the axial skeleton or proximal
extremities, and there were only three cases of chondro-
sarcoma with bony metastases without local recurrence.
There were also some literatures about bony metastases
of extraskeletal myxoid chondrosarcoma and clear cell
chondrosarcoma [15-17]. But, there have been no re-
ports about bony metastases of PC.
The mechanism of bony metastases is not very clear.
Ozaki et al. [14] believed that the metastasis was in the
lumbar spine and may not have been associated with
lung metastases because of the venous connections be-
tween the vertebral and other veins and the absence of a
basement membrane in the capillaries of bone marrow.
Matsumura et al. [18] described that PC microscopically
invaded the underlying cortex through the Volkman
canal in the cortical bone. Andrew et al. [19] reported
that although a chondrosarcoma might metastasize late
or not at all, it could invade and spread through veins.
Death might also result from relentless local growth and
invasion of adjacent vital structures. Therefore, consider-
ing the above literatures, we deduced that tumor cells
had spread through the venules in the Volkman canal
before surgery, which could not be tested by the present
medical equipments. The microscopic cortical invasion
through the Volkman canal and the spread of tumor
cells through veins may be the most likely reason forbony metastases without local recurrence in the present
case. Other cancers which had not been found before
and/or after surgery may be another reason.
In addition, histological grading (grades 1 to 3) for chon-
drosarcomas is related to clinical behavior and prognosis
[9,13]. Grade 1 chondrosarcomas rarely metastasize, while
grade 3 chondrosarcmas develop metastases in 70% of
patients [9]. Ozaki et al. [13] concluded that the median
interval between surgery for the primary lesion and metas-
tases was 10 months and the median survival time after
metastasis of the patients who could not or did not
undergo metastectomy was 5 months (range 0 to
10 months). On the other hand, the survival periods after
metastasis of two patients who underwent metastectomy
were 15 and 29 months. Papagelopoulos et al. [6] also
found patients with grade 2 PC had a worse prognosis than
patients with grade 1 PC in the 5-year metastasis-free sur-
vival (50% versus 94%).
The prognosis of most PC is usually good, but regular
follow-up is still important for the early finding of local re-
lapse or metastases. F-18 FDG PET/CT is a recommended
examination for finding early metastases. Maybe, the pa-
tients with early local metastases will have the opportunity
for metastectomy. For the minority of patients with late
and multiple metastases, whether chemotherapy is applic-
able needs further study. New drugs and other treatments
are also urgently needed.
Conclusions
In conclusion, we reported a rare case which has the fol-
lowing features: (1) the location was the proximal fibula,
not the common location including distal femur, proximal
tibia, and proximal humerus; (2) ‘smoke ring’ pattern of
Figure 5 PET/CT of the patient. F-18 FDG PET/CT shows multiple
bone metastases especially and symmetrically in the axial skeleton
and proximal extremities including bilateral femurs and humeri, with
a maximum SUV of 10.8, but with no signs of local recurrence and
no focal F-18 FDG uptake in the brain, head, neck, chest, and
abdomen except a small nodule in the liver which was suspected
as a calcification.
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has been rarely reported in published literatures; (3) cortical
erosion was shown by MRI and histopathological examin-
ation which was reported only once; (4) the most important
feature is that MBM was shown by F-18 FDG PET/CT
especially and symmetrically in the axial skeleton and prox-
imal extremities including bilateral femurs and humeri; and
(5) the period from surgery to postoperative metastases and
the survival span of our patient was 10 and 6 months, re-
spectively, which was consistent with the previous reports.Finally, we hope this report will increase the under-
standing of this rare bone tumor whose prognosis some-
times deviates from the good expectations.
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